Comparative Expression of Novel Vascular Endothelial Growth Factor/Vascular Permeability Factor Transcripts in Skin, Papillomas, and Carcinomas of v-Ha-rasTg.AC Transgenic Mice and FVB/N Mice
- 29 June 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 247 (3) , 644-653
- https://doi.org/10.1006/bbrc.1998.8787
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC miceCarcinogenesis: Integrative Cancer Research, 1996
- Characterization of the Murine VEGF-Related Factor GeneBiochemical and Biophysical Research Communications, 1996
- The Mouse Gene for Vascular Endothelial Growth FactorJournal of Biological Chemistry, 1996
- Enhanced expression of multiple forms of VEGF is associated with spontaneous immortalization of murine fibroblastsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Focal transgene expression associated with papilloma development in v-Ha-ras–transgenic TG.AC miceMolecular Carcinogenesis, 1994
- Chemically induced skin carcinogenesis in a transgenic mouse line (TG·AC) carrying a v-Ha-ras geneCarcinogenesis: Integrative Cancer Research, 1993
- Induction of epidermal hyperplasia, hyperkeratosis, and papillomas in transgenic mice by a targeted v‐Ha‐ras oncogeneMolecular Carcinogenesis, 1993
- Induction of angiogenesis during the transition from hyperplasia to neoplasiaNature, 1989
- Cutaneous chemical carcinogenesisJournal of the American Academy of Dermatology, 1986
- An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissueNature, 1986